Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yates

Showing results (361-370 of 375) with videos related to

Pageof 38
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|March 11, 2014
Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunctionE G Wilmot, M Leggate, J N Khan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trialT Yates, M J Davies, S M Haffner, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
Drug Discovery Today|June 4, 2013
Model-based drug discovery: implementation and impactSandra A G Visser, Malin Aurell, Rhys D O Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases ActivityPeter Ballard, James W T Yates, Zhenfan Yang, et al.
Open Heart|February 20, 2026
Feasibility, safety and outcomes of a virtual ward with remote monitoring for patients awaiting urgent coronary artery bypass graft surgeryArun Kirupananthavel, Simon Woldman, Daniel A Jones, et al.
Journal of Pharmaceutical Sciences|April 28, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasetsPatrick Poulin, Hannah M Jones, Rhys Do Jones, et al.
Journal of Pharmaceutical Sciences|April 12, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approachRagini Vuppugalla, Punit Marathe, Handan He, et al.
Molecular Cancer Therapeutics|September 12, 2015
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous SchedulesSylvie M Guichard, Jon Curwen, Teeru Bihani, et al.
Journal of Pharmaceutical Sciences|May 5, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearanceBarbara J Ring, Jenny Y Chien, Kimberly K Adkison, et al.
Pageof 38

Showing results (361-370 of 375) with videos related to

Sort By:
Pageof 38
Diabetic Medicine : a Journal of the British Diabetic Association|March 11, 2014
Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunctionE G Wilmot, M Leggate, J N Khan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trialT Yates, M J Davies, S M Haffner, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
Drug Discovery Today|June 4, 2013
Model-based drug discovery: implementation and impactSandra A G Visser, Malin Aurell, Rhys D O Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases ActivityPeter Ballard, James W T Yates, Zhenfan Yang, et al.
Open Heart|February 20, 2026
Feasibility, safety and outcomes of a virtual ward with remote monitoring for patients awaiting urgent coronary artery bypass graft surgeryArun Kirupananthavel, Simon Woldman, Daniel A Jones, et al.
Journal of Pharmaceutical Sciences|April 28, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasetsPatrick Poulin, Hannah M Jones, Rhys Do Jones, et al.
Journal of Pharmaceutical Sciences|April 12, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approachRagini Vuppugalla, Punit Marathe, Handan He, et al.
Molecular Cancer Therapeutics|September 12, 2015
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous SchedulesSylvie M Guichard, Jon Curwen, Teeru Bihani, et al.
Journal of Pharmaceutical Sciences|May 5, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearanceBarbara J Ring, Jenny Y Chien, Kimberly K Adkison, et al.
Pageof 38